The Three Most Common Comorbidities in People with Narcolepsy

At the American Neurological Association (ANA) annual meeting this week, new real-world data was presented identifying comorbidities and demographic characteristics of patients with narcolepsy. Avadel Pharmaceuticals plc provided support for the study, along with three encore presentations related to LUMRYZ, its investigational formulation of sodium oxybate designed to be taken once at bedtime for the … Read more